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Table 1
Cartilage loss (mm) in cases with knee replacement (KR) and matched controls
KLG2 KLG3 KLG4
KR
Cases
Matched
Controls
KR
Cases
Matched
Controls
KR
Cases
Matched
Controls
cMFTC Median -0.15 +0.03 -0.17 -0.12 -0.08 -0.09
Mean -0.57 0.00 -0.26 -0.12 -0.12 -0.09
MFTC Median -0.07 +0.01 -0.13 -0.08 -0.07 -0.05
Mean -0.26 +0.03 -0.18 -0.09 -0.07 -0.05
OV1 Median -0.27 -0.14 -0.29 -0.22 -0.24 -0.20
Mean -0.59 -0.15 -0.37 -0.24 -0.28 -0.25
KR¼ knee replacement; KLG¼ Kellgren Lawrence grade; (c)MFTC¼ (central) medial
femorotibial compartment; OV ¼ ordered value
Abstracts / Osteoarthritis and Cartilage 20 (2012) S10–S53S12dwarﬁsm with impaired matrix degradation of the cartilage primordia
due to decrease of Mmp13 expression, while Sox9-Cre;Hes1ﬂ/ﬂ
embryos exhibited normal sketetal growth. When we created the
experimental OA model in TM-inducible knockout mice, the knee OA
development was suppressed in both Col2a1-CreTM;Rbpjﬂ/ﬂ mice and
Sox9-Cre;Hes1ﬂ/ﬂ mice as compared to the respective control litter-
mates, with prevention of the terminal stage of endochondral ossiﬁ-
cation. ATDC5 cells overexpressing Notch1-ICD showed enhanced
expression of Mmp13 and Hes1 in one-week pellet culture. Further-
more, the enhancement of Mmp13 expressionwas partially canceled by
inhibition of Hes1 expression though the speciﬁc siRNA transfection.
Luciferase analyses revealed that the Hes1 transfection enhanced the
MMP13 promoter activity most potently among the Hes/Hey members.
Conclusion: The Notch/Rbpj/Hes1 signal in chondrocytesmodulates OA
development by induction of MMP13, indicating it as a possible ther-
apeutic target of OA.
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Purpose: Knee OA has been shown to reduce quality of life and increase
health care utilization. In the absence of disease modifying drugs
(DMOADs), knee replacements (KR) are projected to increase to over 3
million annually in the US by 2030. Imaging biomarkers capable of
predicting relevant clinical endpoints, such as KR, may be valuable tools
for testing the efﬁcacy of DMOADs in clinical trials. The purpose of this
study was thus to examine whether MRI-based longitudinal measures
of cartilage loss predict knee replacement, whether prediction differs by
radiographic disease stage, and whether ordered values (OVs) of
subregional cartilage change provide a better prediction than region-
speciﬁc measures.
Methods: Knees from Osteoarthritis Initiative (OAI) participants who
received a KR between 12 and 48 month follow-up (conﬁrmed by
radiography and/or review of hospital records) were studied. One
matched control knee was selected for each KR case from OAI partici-
pants with the same Kellgren Lawrence (KL) grade at baseline (central
X-ray readings strata 0-1, 2, 3, 4), with the same sex and age (within 5 y),
who did not receive a KR during this period. Quantitative measures of
cartilage were obtained from a sagittal 3T DESSwe MRI sequence. The
time point prior to the occurrence of a KR (T0) and that 12 months
earlier (T-1) were analyzed. Segmentation of weight-bearing femoroti-
bial cartilage was performed by 12 readers (Chondrometrics GmbH,
Ainring, Germany) with blinding to acquisition order. Cartilage thick-
ness (ThCtAB) was determined in 16 subregions. The central medial
compartment (cMFTC) was selected as primary endpoint, the total
medial compartment (MFTC) as secondary endpoint, and OVs as
exploratory endpoints. P-values for differences in cartilage loss between
case/control pairs were computed using the Wilcoxon signed rank test,
and AUCs (with adjustment for matching variables) using ROC analysis.
Results: 191 knees of 165 OAI participants received a KR, of whom 109
had central X-ray readings at the time of analysis, MRI data at both T0
and T-1, and a matched control (46 men, 63 women, age 63.88.9, BMI
29.95.0). Longitudinal cartilage loss (Table 1) in cMFTC (p¼0.007,
AUC¼0.59) and MFTC (p¼0.014, AUC¼0.58), over a 12 month period
prior to KR, discriminated signiﬁcantly between KR cases and controls.
Discrimination for cMFTC was greater in KLG2 (n¼20; p¼0.009;
AUC¼0.67) than in KLG3 (n¼39; p¼0.16; AUC¼0.55) or KLG4 (n¼45;
p¼0.65; AUC¼0.54).
OV1 (the subregion with maximal loss in each knee independent of
location) tended to discriminate better between KRs and controls overall
(p¼0.0006, AUC¼0.63) and in KLG2 (p¼0.004, AUC¼0.79) and KLG3
knees (p¼0.02; AUC¼0.62) compared to cMFTC, but the differences in
AUCs did not reach statistical signiﬁcance. OVs 1 through 8 differed
signiﬁcantly between KRs and controls, whereas only 3 (of the 16)
subregions showed signiﬁcant differences between KR and control knees.Conclusions: Quantitative MRI measures of cartilage thickness loss
predict KR, particularly at the earlier stages of radiographic knee OA.
Point estimates for AUCs suggest that OV1 performs better in predicting
KRs than location speciﬁc measures, but with current sample size the
differences did not reach statistical signiﬁcance. The use of OV1
circumvents the need to choose a speciﬁc region a priori as a primary
endpoint and/or to adjust for comparing multiple regions of interest.
Quantitative measures of cartilage loss may be used in clinical trials to
demonstrate efﬁcacy of DMOADs. Also, the current ﬁndings support the
concept that treatments that slowcartilage lossmaydelayor prevent KR.
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Purpose: Osteoarthritis (OA) of the hip can be deﬁned by both radio-
graphic and clinical criteria. Previously, it has been shown that radio-
graphic criteria associate to the shape of the hip. However, it is
unknown whether shape variations of the hip also associate with hip
OA deﬁned by clinical criteria. We aimed to determine the contribution
of hip shape in the prediction of both end-stage OA (THR) and general
clinical OA (ACR criteria) in a prospective cohort.
Methods: Individuals were extracted from the CHECK (cohort hip and
cohort knee) study. CHECK is a prospective cohort study of individuals
with assumed early symptomatic OA of knee or hip. Of the 1002 indi-
viduals, a random subset of 865 had standardized anteroposterior
radiographs (AP) taken at both baseline and 5 years follow-up. AP-pelvic
radiographs of sufﬁcient qualitywere obtained in 723 subjects at baseline
and in 770 subjects at 5 years follow-up. The shape of the proximal femur
and acetabulum on the AP radiographs was assessed using statistical
shapemodelling (SSM). The shapewasdeﬁnedbya set of landmarkpoints
that are positioned along the contour of the bone in the image (Figure 1).
An SSM describes all variation in shape of the complete cohort by several
independent shape aspects calledmodes. Hips that had received TotalHip
Replacement (THR) within 5 years were classiﬁed as end-stage OA and
hips fulﬁlling the ACR criteria after 5 years based on history, physical
examination, and laboratory ﬁndings were classiﬁed as clinical OA. The
association between each mode and both outcome measures was calcu-
lated by Generalized Estimating Equations (GEE), corrected for sex and
age. To correct for multiple testing, a p-value of 0.0017 was used to
determine statistical signiﬁcance (0.05 was divided by the 30 modes
tested). The predictive value of the GEE model including all univariate
signiﬁcantmodeswas then tested by the area under the ROC curve (AUC).
Results: For this study, 682 females (meanage 55.8) and183males (mean
age 56.4) were included. At baseline, 75% of the hips had no signs of OA
(K&L¼0) whereas 25% had doubtful OA (K&L¼1).When corrected for age
and sex, nine modes at baseline associated signiﬁcantly with the devel-
opment of end-stage OA within 5 years (Table 1). For example, mode 12
which resulted in the largest odds ratio of 2.34, illustrates superior joint
space narrowing and overcoverage of the acetabulum. When combining
thesemodes, only the four modes which associatedmost with end-stage
OA (mode 4, 11, 12, 15) were selected for calculating the AUC, to prevent
overﬁtting of the model. The predictive value of those four modes in the
GEE model resulted in an AUC of 0.81. At baseline, no modes associated
signiﬁcantly with the presence of clinical OA at 5 years.
